Medication info

Infosejiseong 10/160 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Intro Biopharma Co., Ltd.
Appearance
Bright yellow oval film-coated tablet
Packaging
30 tablets/PTP (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201603880 · Approved 2016.06.24

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using either component, switching directly to this medication may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more). However, this medication should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medication should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Child dose
The use of this medication is not recommended in pediatric patients under 18 years of age, as its safety and efficacy have not been established.

Ingredients

Manufacturer
Intro Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

This medicine helps lower blood pressure more effectively by combining the effects of two medications for patients with essential hypertension who find blood pressure control difficult with monotherapy using amlodipine or valsartan. High blood pressure can lead to serious complications such as heart disease or stroke, so proper blood pressure management is crucial. This medication helps maintain healthy blood vessel conditions by dilating blood vessels and managing blood pressure stably. By taking this medication when blood pressure control is inadequate, one can reduce the risk of complications and improve quality of life in daily activities. It supports your healthy life through safe and effective blood pressure management. Therefore, this product is used for the treatment of essential hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using either component, switching directly to this medication may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more). However, this medication should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medication should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Child dose

The use of this medication is not recommended in pediatric patients under 18 years of age, as its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so if pregnancy is confirmed, it should be discontinued immediately. Patients with allergies to the active ingredient, women who are pregnant or nursing, patients with severe renal or liver dysfunction, and certain heart disease patients should not take this medication. Patients with a deficiency of sodium or body fluids are at risk of hypotension, so it is necessary to check their condition before taking this medication and monitor blood pressure and condition closely during treatment. Patients with high potassium levels should be cautious about combining this medication with potassium-increasing drugs and should regularly check potassium levels. Patients with vascular issues in the kidneys or those who have recently undergone a kidney transplant should also be cautious when taking this medication. This medication can cause a serious allergic reaction known as angioedema, which involves swelling of the face, lips, or tongue, and if such symptoms occur, the medication should be discontinued immediately. Patients with heart failure or after myocardial infarction should carefully monitor renal function and blood pressure while taking this medication. Dizziness or fatigue may occur during driving or operating machinery, so caution is advised. When combined with other antihypertensive medications, the risk of hypotension, renal function impairment, and hyperkalemia may increase, so it should be taken according to a physician's instructions. It is safe for women who are pregnant or planning to become pregnant to avoid this medication, and nursing women should also refrain from use. The safety and efficacy of this medication in children under 18 years of age have not been adequately established, so its use is not recommended. In case of overdose, hypotension, dizziness, or in severe cases, shock may occur, so the prescribed dosage should be strictly followed and any abnormal symptoms should be reported to healthcare professionals immediately.

Side effects

  • Nasopharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • headache
  • dizziness
  • drowsiness
  • position-induced dizziness
  • sensory disturbance
Show 116 more
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • pharyngeal and laryngeal pain
  • diarrhea
  • nausea
  • abdominal pain
  • constipation
  • dry mouth
  • rash
  • erythema
  • sweating
  • rash
  • itching
  • joint swelling
  • low back pain
  • arthritis
  • muscle spasms
  • lethargy
  • polyuria
  • nocturia
  • erectile dysfunction
  • edema
  • localized swelling
  • facial swelling
  • peripheral edema
  • fatigue
  • flushing
  • asthenia
  • facial flushing
  • decreased hemoglobin
  • decreased hematocrit
  • neutropenia
  • thrombocytopenia
  • serum sickness
  • increased serum potassium
  • vasculitis
  • elevated liver function tests
  • angioedema
  • myalgia
  • renal failure
  • kidney injury
  • increased serum creatinine
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory infection
  • viral infection
  • diplopia
  • thrombocytopenic purpura
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremor
  • sensory loss
  • taste disturbance
  • peripheral neuropathy
  • hypertonia
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • dyspnea
  • rhinitis
  • vomiting
  • dyspepsia
  • pancreatitis
  • gastritis
  • gingival hyperplasia
  • hepatitis
  • jaundice
  • alopecia
  • purpura
  • skin depigmentation
  • photosensitivity reaction
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • myalgia
  • dysuria
  • nocturnal enuresis
  • gynecomastia
  • pain
  • fatigue
  • chest pain
  • weight loss
  • weight gain
  • increased liver enzymes
  • chest discomfort
  • abdominal discomfort
  • gastroesophageal reflux disease
  • neck pain
  • hypercholesterolemia
  • hypoglycemia
  • neuroexcitation
  • Stevens-Johnson syndrome
  • chest pain
  • weight gain
  • arthralgia
  • skeletal pain
  • rhabdomyolysis
  • gingival hyperplasia
  • gastritis
  • sensory loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and it is recommended to keep it at room temperature between 1°C and 30°C. Storing it this way helps maintain the medication's efficacy and allows for safe use.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablet

Package unit

30 tablets/PTP (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.